Skip to main content
NCBI home page
Annals of the Rheumatic Diseases logoLink to Annals of the Rheumatic Diseases
. 2004 Feb;63(2):162–169. doi: 10.1136/ard.2003.006296

Development of the PsAQoL: a quality of life instrument specific to psoriatic arthritis

S McKenna 1, L Doward 1, D Whalley 1, A Tennant 1, P Emery 1, D Veale 1
PMCID: PMC1754880  PMID: 14722205

Abstract

Background: Patient reported outcome measures used in studies of psoriatic arthritis (PsA) have been found to be inadequate for determining the impact of the disease from the patient's perspective.

Objective: To produce the PsAQoL, a PsA-specific quality of life (QoL) instrument, employing the needs based model of QoL that would be relevant and acceptable to respondents, valid, and reliable.

Methods: Content was derived from qualitative interviews conducted with patients with PsA. Face and content validity were assessed by field test interviews with a new sample of patients with PsA. A postal survey was conducted to improve the scaling properties of the new measure. Finally, a test-retest postal survey was used to identify the final measure and to test its scaling properties, reliability, internal consistency, and validity.

Results: Analysis of the qualitative interview transcripts identified a 51 item questionnaire. Field test interviews confirmed the acceptability and relevance of the measure. Analysis of data from the first postal survey (n = 94) reduced the questionnaire to 35 items. Rasch analysis of data from the test-retest survey (n = 286) identified a 20 item version of the PsAQoL with good item fit. This version had excellent internal consistency (α = 0.91), test-retest reliability (0.89), and validity.

Conclusions: The PsAQoL is a valuable tool for assessing the impact of interventions for PsA in clinical studies and trials. It is well accepted by patients, taking about three minutes to complete, is easy to administer, and has excellent scaling and psychometric properties.

Full Text

The Full Text of this article is available as a PDF (315.6 KB).

Figure 1 .

Figure 1

Open in a new tab

Associations between PsAQoL scores and disease severity and activity.

Figure 2 .

Figure 2

Open in a new tab

Associations between PsAQoL scores and patients' ratings of general health, quality of life, and visibility of skin lesions.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Berzon R., Hays R. D., Shumaker S. A. International use, application and performance of health-related quality of life instruments. Qual Life Res. 1993 Dec;2(6):367–368. doi: 10.1007/BF00422214. [DOI] [PubMed] [Google Scholar]
  2. Blackmore M. G., Gladman D. D., Husted J., Long J. A., Farewell V. T. Measuring health status in psoriatic arthritis: the Health Assessment Questionnaire and its modification. J Rheumatol. 1995 May;22(5):886–893. [PubMed] [Google Scholar]
  3. Brazier J. E., Harper R., Jones N. M., O'Cathain A., Thomas K. J., Usherwood T., Westlake L. Validating the SF-36 health survey questionnaire: new outcome measure for primary care. BMJ. 1992 Jul 18;305(6846):160–164. doi: 10.1136/bmj.305.6846.160. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Doward L. C., McKenna S. P., Kohlmann T., Niero M., Patrick D., Spencer B., Thorsen H. The international development of the RGHQoL: a quality of life measure for recurrent genital herpes. Qual Life Res. 1998 Feb;7(2):143–153. doi: 10.1023/a:1008857426633. [DOI] [PubMed] [Google Scholar]
  5. Doward L. C., Spoorenberg A., Cook S. A., Whalley D., Helliwell P. S., Kay L. J., McKenna S. P., Tennant A., van der Heijde D., Chamberlain M. A. Development of the ASQoL: a quality of life instrument specific to ankylosing spondylitis. Ann Rheum Dis. 2003 Jan;62(1):20–26. doi: 10.1136/ard.62.1.20. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Duffy C. M., Watanabe Duffy K. N., Gladman D. D., Brubacher B. B., Buskila D., Langevitz P., Farewell V. T. The utility of the arthritis impact measurement scales for patients with psoriatic arthritis. J Rheumatol. 1992 Nov;19(11):1727–1732. [PubMed] [Google Scholar]
  7. Gladman D. D., Espinoza L. R. International symposium on psoriatic arthritis. J Rheumatol. 1992 Feb;19(2):290–291. [PubMed] [Google Scholar]
  8. Gupta A. K., Grober J. S., Hamilton T. A., Ellis C. N., Siegel M. T., Voorhees J. J., McCune W. J. Sulfasalazine therapy for psoriatic arthritis: a double blind, placebo controlled trial. J Rheumatol. 1995 May;22(5):894–898. [PubMed] [Google Scholar]
  9. Husted J. A., Gladman D. D., Cook R. J., Farewell V. T. Responsiveness of health status instruments to changes in articular status and perceived health in patients with psoriatic arthritis. J Rheumatol. 1998 Nov;25(11):2146–2155. [PubMed] [Google Scholar]
  10. Husted J. A., Gladman D. D., Farewell V. T., Long J. A., Cook R. J. Validating the SF-36 health survey questionnaire in patients with psoriatic arthritis. J Rheumatol. 1997 Mar;24(3):511–517. [PubMed] [Google Scholar]
  11. Husted J. A., Gladman D. D., Long J. A., Farewell V. T. A modified version of the Health Assessment Questionnaire (HAQ) for psoriatic arthritis. Clin Exp Rheumatol. 1995 Jul-Aug;13(4):439–443. [PubMed] [Google Scholar]
  12. Husted J., Gladman D. D., Farewell V. T., Long J. A. Validation of the revised and expanded version of the Arthritis Impact Measurement Scales for patients with psoriatic Arthritis. J Rheumatol. 1996 Jun;23(6):1015–1019. [PubMed] [Google Scholar]
  13. Husted J., Gladman D. D., Long J. A., Farewell V. T. Relationship of the Arthritis Impact Measurement Scales to changes in articular status and functional performance in patients with psoriatic arthritis. J Rheumatol. 1996 Nov;23(11):1932–1937. [PubMed] [Google Scholar]
  14. McKenna S. P., Cook S. A., Whalley D., Doward L. C., Richards H. L., Griffiths C. E. M., Van Assche D. Development of the PSORIQoL, a psoriasis-specific measure of quality of life designed for use in clinical practice and trials. Br J Dermatol. 2003 Aug;149(2):323–331. doi: 10.1046/j.1365-2133.2003.05492.x. [DOI] [PubMed] [Google Scholar]
  15. Nichol M. B., Margolies J. E., Lippa E., Rowe M., Quell J. The application of multiple quality-of-life instruments in individuals with mild-to-moderate psoriasis. Pharmacoeconomics. 1996 Dec;10(6):644–653. doi: 10.2165/00019053-199610060-00010. [DOI] [PubMed] [Google Scholar]
  16. Rapp S. R., Feldman S. R., Exum M. L., Fleischer A. B., Jr, Reboussin D. M. Psoriasis causes as much disability as other major medical diseases. J Am Acad Dermatol. 1999 Sep;41(3 Pt 1):401–407. doi: 10.1016/s0190-9622(99)70112-x. [DOI] [PubMed] [Google Scholar]
  17. Ruta D. A., Abdalla M. I., Garratt A. M., Coutts A., Russell I. T. SF 36 health survey questionnaire: I. Reliability in two patient based studies. Qual Health Care. 1994 Dec;3(4):180–185. doi: 10.1136/qshc.3.4.180. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Taccari E., Spadaro A., Rinaldi T., Riccieri V., Sensi F. Comparison of the Health Assessment Questionnaire and Arthritis Impact Measurement Scale in patients with psoriatic arthritis. Rev Rhum Engl Ed. 1998 Dec;65(12):751–758. [PubMed] [Google Scholar]
  19. Veale D., Rogers S., Fitzgerald O. Classification of clinical subsets in psoriatic arthritis. Br J Rheumatol. 1994 Feb;33(2):133–138. doi: 10.1093/rheumatology/33.2.133. [DOI] [PubMed] [Google Scholar]
  20. Verhoeven A. C., Boers M., van Der Linden S. Responsiveness of the core set, response criteria, and utilities in early rheumatoid arthritis. Ann Rheum Dis. 2000 Dec;59(12):966–974. doi: 10.1136/ard.59.12.966. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Wagner T. H., Patrick D. L., McKenna S. P., Froese P. S. Cross-cultural development of a quality of life measure for men with erection difficulties. Qual Life Res. 1996 Aug;5(4):443–449. doi: 10.1007/BF00449919. [DOI] [PubMed] [Google Scholar]
  22. Whalley D., McKenna S. P., de Jong Z., van der Heijde D. Quality of life in rheumatoid arthritis. Br J Rheumatol. 1997 Aug;36(8):884–888. doi: 10.1093/rheumatology/36.8.884. [DOI] [PubMed] [Google Scholar]
  23. Wolfe Frederick, Flowers Nancy, Burke Thomas A., Arguelles Lester M., Pettitt Dan. Increase in lifetime adverse drug reactions, service utilization, and disease severity among patients who will start COX-2 specific inhibitors: quantitative assessment of channeling bias and confounding by indication in 6689 patients with rheumatoid arthritis and osteoarthritis. J Rheumatol. 2002 May;29(5):1015–1022. [PubMed] [Google Scholar]
  24. Zangger P., Gladman D. D., Bogoch E. R. Musculoskeletal surgery in psoriatic arthritis. J Rheumatol. 1998 Apr;25(4):725–729. [PubMed] [Google Scholar]
  25. de Jong Z., van der Heijde D., McKenna S. P., Whalley D. The reliability and construct validity of the RAQoL: a rheumatoid arthritis-specific quality of life instrument. Br J Rheumatol. 1997 Aug;36(8):878–883. doi: 10.1093/rheumatology/36.8.878. [DOI] [PubMed] [Google Scholar]

Articles from Annals of the Rheumatic Diseases are provided here courtesy of BMJ Publishing Group

RESOURCES